Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 280 participants.
Also called NCT06841965
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 280 participants
- Registry
-
NCT06841965
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT06841965. Randomized; double masking; primary purpose treatment. Start 2025-03-01 (anticipated); primary completion 2027-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
- Condition
- Stroke
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Intravenous thrombolysis
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Record details
- Record id
cardio:ct-nct06841965- Content hash
24ef50a16595bcee9025715b802b35520128ba564eaa70a25be5fc3809ede940